Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Myalepta (metreleptin) for the Treatment of Lipodystrophy

Drug Name

Myalepta® (metreleptin)

Developer

AstraZeneca, Novelion Therapeutics

Therapy Class

Leptin analogue

Product Description

Recombinant methionyl-human leptin

Current Indication

Lipodystrophy

Market Sector

Metabolism

Development Status

Approved in the US and Europe
Expand
Close
Close
Close

Go Top